We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+8.95%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$61.1B
AUM Growth
+$4.73B
(+8.4%)
Cap. Flow
+$390M
Cap. Flow
% of AUM
0.64%
Top 10 Holdings %
Top 10 Hldgs %
17.66%
Holding
2,331
New
154
Increased
918
Reduced
1,058
Closed
154
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.6% |
| 2 | Consumer Discretionary | 14.64% |
| 3 | Healthcare | 14.47% |
| 4 | Industrials | 11.01% |
| 5 | Consumer Staples | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Syndax Pharmaceuticals
SNDX
$1.82B
| $418K | ﹤0.01% |
18,680
-11,283
| -38% | -$255K |
|
1902
Atomera
ATOM
$210M
| $416K | ﹤0.01% |
16,970
-597
| -3% | -$17.5K |
|
1903
Simmons First National
SFNC
$3.4B
| $416K | ﹤0.01% |
14,027
-20,823
| -60% | -$585K |
|
|
WDR
1904
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $415K | ﹤0.01% |
16,563
-15,025
| -48% | -$377K |
|
1905
Viasat
VSAT
$11.7B
| $414K | ﹤0.01% |
8,625
+49
| +0.6% | +$2.37K |
|
|
AVNS
1906
DELISTED
Avanos Medical
AVNS
| $410K | ﹤0.01% |
9,369
-1,708
| -15% | -$80.2K |
|
1907
Carriage Services
CSV
$544M
| $409K | ﹤0.01% |
11,635
-2,482
| -18% | -$86.1K |
|
1908
Steven Madden
SHOO
$3.58B
| $408K | ﹤0.01% |
10,951
-7,522
| -41% | -$274K |
|
|
BCPC
1909
Balchem Corp
BCPC
$5.65B
| $408K | ﹤0.01% |
3,252
+1,352
| +71% | +$164K |
|
|
FLOW
1910
DELISTED
SPX FLOW, Inc.
FLOW
| $407K | ﹤0.01% |
+6,433
| New | +$389K |
|
1911
City Holding Co
CHCO
$2.04B
| $406K | ﹤0.01% |
+4,967
| New | +$378K |
|
1912
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $406K | ﹤0.01% |
4,577
-7,237
| -61% | -$573K |
|
1913
RCI Hospitality Holdings
RICK
$207M
| $404K | ﹤0.01% |
6,349
+1,131
| +22% | +$60.9K |
|
1914
Agilysys
AGYS
$3.02B
| $403K | ﹤0.01% |
8,404
-4,387
| -34% | -$218K |
|
1915
Enanta Pharmaceuticals
ENTA
$402M
| $403K | ﹤0.01% |
8,174
-27,623
| -77% | -$1.38M |
|
1916
PDF Solutions
PDFS
$2.01B
| $402K | ﹤0.01% |
22,591
-10,534
| -32% | -$209K |
|
|
ALTR
1917
DELISTED
Altair Engineering Inc
ALTR
| $401K | ﹤0.01% |
6,408
-2,184
| -25% | -$133K |
|
|
DHC
1918
Diversified Healthcare Trust
DHC
$2.04B
| $400K | ﹤0.01% |
83,769
-17,358
| -17% | -$79.9K |
|
1919
Triumph Financial Inc
TFIN
$1.8B
| $398K | ﹤0.01% |
5,144
| – | – |
|
|
NSA
1920
DELISTED
National Storage Affiliates Trust
NSA
| $397K | ﹤0.01% |
9,942
+240
| +2% | +$9.13K |
|
1921
Novanta
NOVT
$6.2B
| $396K | ﹤0.01% |
3,002
-6,196
| -67% | -$814K |
|
1922
Orion Energy Systems
OESX
$78.3M
| $396K | ﹤0.01% |
5,689
-6,649
| -54% | -$621K |
|
1923
Rithm Capital
RITM
$5.65B
| $395K | ﹤0.01% |
35,103
+1,845
| +6% | +$18.8K |
|
|
KNL
1924
DELISTED
Knoll, Inc.
KNL
| $395K | ﹤0.01% |
23,950
+3,376
| +16% | +$55.2K |
|
|
AWH
1925
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
| $394K | ﹤0.01% |
3,896
-1,087
| -22% | -$119K |
|
Similar funds
VGA
AQR Capital Management's Q1 2021 Portfolio in Review
As of Q1 2021, AQR Capital Management held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
AQR Capital Management's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- AQR Capital Management added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- AQR Capital Management's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- AQR Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- AQR Capital Management's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- AQR Capital Management opened 154 new positions and closed 154 in Q1 2021.
- AQR Capital Management's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.